Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Barocas JA, Gai MJ, Amuchi B, Jawa R, Linas BP. Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections. Drug Alcohol Depend. 2020 Oct 1;215:108207. doi: 10.1016/j.drugalcdep.2020.108207. Epub 2020 Aug 1. PubMed PMID: 32795883; PubMed Central PMCID: PMC7502512.
Thakarar K, Walley AY, Heeren TC, Winter MR, Ventura AS, Sullivan M, Drainoni M, Saitz R. Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders. AIDS Care. 2020 Sep;32(9):1177-1181. doi: 10.1080/09540121.2019.1683805. Epub 2019 Nov 5. PubMed PMID: 31686528; PubMed Central PMCID: PMC7198361.
Kimmel SD, Miller NS. The Clinical Microbiology Laboratory and the Opioid Epidemic: Challenges and Opportunities. Infect Dis Clin North Am. 2020 Sep;34(3):465-478. doi: 10.1016/j.idc.2020.06.005. Review. PubMed PMID: 32782096; PubMed Central PMCID: PMC7428057.
Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M. Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis. Clin Infect Dis. 2020 Jul 27;71(3):480-487. doi: 10.1093/cid/ciz834. PubMed PMID: 31598642; PubMed Central PMCID: PMC7384313.
Kimmel SD, Del Rio C. Improving Outcomes for People With Injection Drug-related Endocarditis: Are Medications for Opioid Use Disorder Enough?. J Addict Med. 2020 Jul/Aug;14(4):280-0. doi: 10.1097/ADM.0000000000000573. PubMed PMID: 31634203; PubMed Central PMCID: PMC7165029.
Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. Am J Med. 2020 Jun 27;. doi: 10.1016/j.amjmed.2020.05.029. [Epub ahead of print] PubMed PMID: 32603791; NIHMSID:NIHMS1607562.
Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 May;112:42-48. doi: 10.1016/j.jsat.2020.01.017. Epub 2020 Jan 30. PubMed PMID: 32199545.
Masuku SD, Berhanu R, Van Rensburg C, Ndjeka N, Rosen S, Long L, Evans D, Nichols BE. Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis. Int J Tuberc Lung Dis. 2020 Apr 1;24(4):376-382. doi: 10.5588/ijtld.19.0409. PubMed PMID: 32317060; NIHMSID:NIHMS1636092.
Sinha P, Shenoi SV, Friedland GH. Opportunities for community health workers to contribute to global efforts to end tuberculosis. Glob Public Health. 2020 Mar;15(3):474-484. doi: 10.1080/17441692.2019.1663361. Epub 2019 Sep 13. PubMed PMID: 31516079; PubMed Central PMCID: PMC7028491.
Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 Dec 10;322(22):2245-2248. doi: 10.1001/jama.2019.16196. PubMed PMID: 31821424; PubMed Central PMCID: PMC7081751.
Jamieson L, Evans D, Berhanu R, Ismail N, Aucock S, Wallengren K, Long L. Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa. BMC Public Health. 2019 Dec 5;19(1):1638. doi: 10.1186/s12889-019-7965-9. PubMed PMID: 31805982; PubMed Central PMCID: PMC6896407.
Bellerose M, Zhu L, Hagan LM, Thompson WW, Randall LM, Malyuta Y, Salomon JA, Linas BP. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. Int J Drug Policy. 2019 Nov 15;:102580. doi: 10.1016/j.drugpo.2019.10.006. [Epub ahead of print] PubMed PMID: 31740175.
Bakalski I, Lyons J, Sinha P. Method and apparatus for measuring the stability of large lateral transfer retroreflectors through a single optical port. Rev Sci Instrum. 2019 Nov 1;90(11):115113. doi: 10.1063/1.5096660. PubMed PMID: 31779423.
Berry KM, Rodriguez CA, Berhanu RH, Ismail N, Mvusi L, Long L, Evans D. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa. BMC Public Health. 2019 Jul 22;19(1):973. doi: 10.1186/s12889-019-7257-4. PubMed PMID: 31331311; PubMed Central PMCID: PMC6647101.
Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. J Hepatol. 2019 Jul;71(1):62-70. doi: 10.1016/j.jhep.2019.02.011. Epub 2019 Feb 21. PubMed PMID: 30797050; PubMed Central PMCID: PMC7014921.
Barocas JA, So-Armah K, Cheng DM, Lioznov D, Baum M, Gallagher K, Fuster D, Gnatienko N, Krupitsky E, Freiberg MS, Samet JH. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia. PLoS One. 2019;14(6):e0218852. doi: 10.1371/journal.pone.0218852. eCollection 2019. PubMed PMID: 31246992; PubMed Central PMCID: PMC6597160.
van Rensburg C, Berhanu R, Hirasen K, Evans D, Rosen S, Long L. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2019;14(6):e0217820. doi: 10.1371/journal.pone.0217820. eCollection 2019. PubMed PMID: 31170207; PubMed Central PMCID: PMC6553851.
Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE. Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant. Am J Transplant. 2019 Jun;19(6):1806-1819. doi: 10.1111/ajt.15239. Epub 2019 Jan 25. PubMed PMID: 30589503; PubMed Central PMCID: PMC6538449.
Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019 Jun;34(6):1039-1042. doi: 10.1007/s11606-018-4801-3. Epub 2019 Feb 6. Review. PubMed PMID: 30729416; PubMed Central PMCID: PMC6544670.
Kimmel SD, Jawa R, Walley AY, Barlam TF. Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics. Ann Intern Med. 2019 Apr 2;170(7):508-509. doi: 10.7326/L19-0040. PubMed PMID: 30934072.
Epstein RL, Bhagavathula M, Saag LA, Verma S, Kan CK, Mesick J, Kamineni P, White LF, Barnett ED, Salgame P, Hochberg NS. QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA. Int J Tuberc Lung Dis. 2019 Apr 1;23(4):482-490. doi: 10.5588/ijtld.18.0540. PubMed PMID: 31064628; PubMed Central PMCID: PMC6690781.
Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, Randall L, Salomon JA, Linas BP. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstet Gynecol. 2019 Feb;133(2):289-300. doi: 10.1097/AOG.0000000000003062. PubMed PMID: 30633134; PubMed Central PMCID: PMC6501827.
Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 Jan;56(1):8-16. doi: 10.1016/j.amepre.2018.08.016. Epub 2018 Nov 19. PubMed PMID: 30467088; PubMed Central PMCID: PMC6312183.
Tasillo A, Linas BP. Decision Science at Work: The Case of Latent Tuberculosis Screening. Am J Kidney Dis. 2019 Jan;73(1):8-10. doi: 10.1053/j.ajkd.2018.09.009. PubMed PMID: 30579384.
Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec;108(12):1675-1681. doi: 10.2105/AJPH.2018.304673. Epub 2018 Oct 25. PubMed PMID: 30359112; PubMed Central PMCID: PMC6236756.
Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, Christiansen CL, Linas BP. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS. 2018 Nov 28;32(18):2787-2798. doi: 10.1097/QAD.0000000000002014. PubMed PMID: 30234602; PubMed Central PMCID: PMC6805137.
Schechter-Perkins EM, Miller NS, Hall J, Hartman JJ, Dorfman DH, Andry C, Linas BP. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med. 2018 Nov;25(11):1216-1226. doi: 10.1111/acem.13484. Epub 2018 Jul 20. PubMed PMID: 29851238; PubMed Central PMCID: PMC6957127.
Linas BP. Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction. 2018 Jul;113(7):1274-1275. doi: 10.1111/add.14219. PubMed PMID: 29883035.
Linas BP, Nolen S. A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am. 2018 Jun;32(2):447-459. doi: 10.1016/j.idc.2018.02.013. Review. PubMed PMID: 29778265; PubMed Central PMCID: PMC6085105.
Rodriguez CV, Rubenstein KB, Linas B, Hu H, Horberg M. Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care. 2018 May 1;24(5):e134-e140. PubMed PMID: 29851444; PubMed Central PMCID: PMC6132051.
Schackman BR, Gutkind S, Morgan JR, Leff JA, Behrends CN, Delucchi KL, McKnight C, Perlman DC, Masson CL, Linas BP. Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend. 2018 Apr 1;185:411-420. doi: 10.1016/j.drugalcdep.2017.11.031. Epub 2018 Feb 21. PubMed PMID: 29477574; PubMed Central PMCID: PMC5889754.
Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3. PubMed PMID: 28733097; PubMed Central PMCID: PMC5750108.
Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 Dec;36(12):2142-2150. doi: 10.1377/hlthaff.2017.0684. PubMed PMID: 29200354; PubMed Central PMCID: PMC5721349.
Losina E, Hyle EP, Borre ED, Linas BP, Sax PE, Weinstein MC, Rusu C, Ciaranello AL, Walensky RP, Freedberg KA. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 Oct 15;65(8):1266-1271. doi: 10.1093/cid/cix547. PubMed PMID: 28605504; PubMed Central PMCID: PMC5850036.
Barocas JA, Beiser M, León C, Gaeta JM, O'Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 Jun 1;177(6):880-882. doi: 10.1001/jamainternmed.2017.0358. PubMed PMID: 28395004; PubMed Central PMCID: PMC5575839.
Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 Jan 1;64(1):100-101. doi: 10.1093/cid/ciw680. Epub 2016 Nov 3. PubMed PMID: 27815292.
Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017 Winter;4(1):ofw266. doi: 10.1093/ofid/ofw266. eCollection 2017 Winter. PubMed PMID: 28480259; PubMed Central PMCID: PMC5414108.
Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017;28(4):1333-1344. doi: 10.1353/hpu.2017.0118. PubMed PMID: 29176099; PubMed Central PMCID: PMC5873974.
Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Sep 6;165(5):345-55. doi: 10.7326/M16-0065. Epub 2016 Jun 21. Review. PubMed PMID: 27322622; PubMed Central PMCID: PMC5345254.
Linas BP. Understanding Cost and Value in Hepatitis C Therapy. Top Antivir Med. 2016 Jul/Aug;24(2):93-97. Review. PubMed PMID: 27841979; PubMed Central PMCID: PMC6148929.
Carey KJ, Huang W, Linas BP, Tsui JI. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. J Subst Abuse Treat. 2016 Jul;66:54-9. doi: 10.1016/j.jsat.2016.01.009. Epub 2016 Feb 13. PubMed PMID: 26988423; PubMed Central PMCID: PMC5097249.
Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar;3(2):ofw075. doi: 10.1093/ofid/ofw075. eCollection 2016 Mar. PubMed PMID: 27191007; PubMed Central PMCID: PMC4867657.
Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr;23(4):274-81. doi: 10.1111/jvh.12489. Epub 2015 Nov 17. PubMed PMID: 26572798; PubMed Central PMCID: PMC5481196.
Linas BP. Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries. J Infect Dis. 2015 Aug 15;212(4):513-5. doi: 10.1093/infdis/jiv041. Epub 2015 Mar 12. PubMed PMID: 25767215.
Pho MT, Jensen DM, Meltzer DO, Kim AY, Linas BP. Clinical impact of treatment timing for chronic hepatitis C infection: a decision model. J Viral Hepat. 2015 Aug;22(8):630-8. doi: 10.1111/jvh.12412. PubMed PMID: 26135026; PubMed Central PMCID: PMC4515086.
Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5;162(9):619-29. doi: 10.7326/M14-1313. PubMed PMID: 25820703; PubMed Central PMCID: PMC4420667.
Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015 Jan;110(1):129-43. doi: 10.1111/add.12754. PubMed PMID: 25291977; PubMed Central PMCID: PMC4270906.
Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. Clin Infect Dis. 2014 Dec 15;59(12):1686-93. doi: 10.1093/cid/ciu698. Epub 2014 Sep 3. PubMed PMID: 25186591; PubMed Central PMCID: PMC4311177.
Pho MT, Linas BP. Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul;60(1):12-4. doi: 10.1002/hep.27220. PubMed PMID: 24825115; PubMed Central PMCID: PMC4096113.
Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014;9(5):e97317. doi: 10.1371/journal.pone.0097317. eCollection 2014. PubMed PMID: 24842841; PubMed Central PMCID: PMC4026319.
What would you like to do?